Products - Arthritis | Topic

Showing 16 products

Date | Sort by Title

Status: In developmentRemove ‘Status: In development’ filter

Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs [ID1399]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
13 July 2022
Upadacitinib for treating active ankylosing spondylitis [ID3848]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
17 August 2022
Tofacitinib for treating active ankylosing spondylitis [ID3865]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
17 August 2022
Osteoarthritis: care and management (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
19 October 2022
Upadacitinib for treating active non-radiographic axial spondyloarthritis [ID3958]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
31 January 2023
GID-MT570 AposHealth for osteoarthritis (OA) of the knee
Status:
In development
Programme:
Medical technologies guidance
Expected publication date:
31 March 2023
Osteoarthritis - naproxcinod [ID417]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Rheumatoid arthritis (after the failure of conventional DMARDs) -rituximab [ID333]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Osteoarthritis - diacerein [ID332]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sirukumab for previously treated moderate to severe active rheumatoid arthritis (ID1002)
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Secukinumab for treating enthesitis-related arthritis or juvenile psoriatic arthritis [ID3738]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tanezumab for treating moderate to severe chronic pain caused by osteoarthritis [ID1603]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sternoclavicular joint replacement for arthritis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Total hip arthroplasty using the superpath approach for osteoarthritis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
GID-MT575 GaitSmart rehabilitation exercise programme
Status:
In development
Programme:
Medical technologies guidance
Expected publication date:
TBC

Arthritis Products

Filter

Product type

Guidance programme

Status
1 selected

New and updated

Showing 16 products

Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs [ID1399]

Upadacitinib for treating active ankylosing spondylitis [ID3848]

Tofacitinib for treating active ankylosing spondylitis [ID3865]

Osteoarthritis: care and management (update)

Upadacitinib for treating active non-radiographic axial spondyloarthritis [ID3958]

GID-MT570 AposHealth for osteoarthritis (OA) of the knee

Osteoarthritis - naproxcinod [ID417]

Rheumatoid arthritis (after the failure of conventional DMARDs) -rituximab [ID333]

Osteoarthritis - diacerein [ID332]

Sirukumab for previously treated moderate to severe active rheumatoid arthritis (ID1002)

High tibial osteotomy with adjustable magnetic nail insertion for symptomatic medial knee osteoarthritis

Secukinumab for treating enthesitis-related arthritis or juvenile psoriatic arthritis [ID3738]

Tanezumab for treating moderate to severe chronic pain caused by osteoarthritis [ID1603]

Sternoclavicular joint replacement for arthritis

Total hip arthroplasty using the superpath approach for osteoarthritis

GID-MT575 GaitSmart rehabilitation exercise programme

Arthritis Products

Filter

Product type

Guidance programme

Status1 selected

New and updated

Showing 16 products

Status
1 selected